Selegiline Patch for Treatment of Nicotine Dependence

Completed · Phase 2 · Has a placebo group

Conditions studied: Tobacco Use Disorder

In brief

Relapse to smoking is a common problem affecting smokers who seek treatment. The purpose of this study is examine whether selegiline, given in the form of a skin patch, is effective in stopping smoking.

Key facts

Study ID

NCT01330030

Run by

Stanford University

People needed

243

Starts

2005-07-01

Expected to finish

2011-07-01

Last updated by the study team

2016-08-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Smokes greater than 20 cigarettes per day

You may not qualify if…

• History of Parkinson's disease, high blood pressure, or severe liver or kidney disease
• Current substance abuse
• Mental illness
• Skin conditions that could interfere with patch use
• Using antidepressant medications (e.g., levodopa/carbidopa, methyldopa, or any MAO inhibitor)
• Pregnant or breastfeeding

Where it is running

• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.